Fay J. Hlubocky, Ph.D. - Publications

Affiliations: 
2010 Illinois Institute of Technology, Chicago, IL, United States 
Area:
Clinical Psychology, Oncology, Medical Ethics

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hlubocky FJ, Daugherty CK, Peppercorn J, Young K, Wroblewski KE, Yamada SD, Lee NK. Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors. Jco Clinical Cancer Informatics. 6: e2200035. PMID 35985004 DOI: 10.1200/CCI.22.00035  0.337
2022 Javellana M, Hlubocky FJ, Somasegar S, Sorkin M, Kurnit KC, Jani I, Stock E, Mills K, Lengyel E, Lee NK. Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer. Jco Oncology Practice. OP2100514. PMID 35201895 DOI: 10.1200/OP.21.00514  0.311
2021 Hoppenot C, Hlubocky FJ, Chor J, Yamada SD, Lee NK. Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 34287689 DOI: 10.1007/s00520-021-06441-0  0.302
2021 Hlubocky FJ, Shanafelt TD, Back AL, Paice JA, Tetzlaff ED, Friese CR, Kamal AH, McFarland DC, Lyckholm L, Gallagher CM, Chatwal M, Saltzman J, Dudzinski D, Burke JM, James TA, et al. Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 41: e339-e353. PMID 34061565 DOI: 10.1200/EDBK_320873  0.319
2021 Cipriano-Steffens T, Cursio JF, Hlubocky F, Sumner M, Garnigan-Peters D, Powell J, Arndt N, Phillips L, Lassiter RH, Gilliam M, Petty LE, Pastor RSO, Malec M, Fitchett G, Polite B. Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate Program. The American Journal of Hospice & Palliative Care. 1049909121995413. PMID 33663241 DOI: 10.1177/1049909121995413  0.325
2021 Hlubocky FJ, Sher TG, Cella D, Wroblewski KE, Peppercorn J, Daugherty CK. Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. Jco Oncology Practice. 17: e101-e110. PMID 33567241 DOI: 10.1200/OP.20.00646  0.742
2020 McFarland DC, Blackler L, Hlubocky FJ, Saracino R, Masciale J, Chin M, Alici Y, Voigt L. Decisional Capacity Determination In Patients With Cancer. Oncology (Williston Park, N.Y.). 34: 203-210. PMID 32609867 DOI: 10.46883/Onc.3406.0203  0.392
2020 Hlubocky FJ, McFarland DF, Spears PA, Smith L, Patten B, Peppercorn J, Holcombe R. Direct-to-Consumer Advertising for Cancer Centers and Institutes: Ethical Dilemmas and Practical Implications. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 40: 1-11. PMID 32379986 DOI: 10.1200/EDBK_279963  0.358
2020 Shanafelt TD, Kamal AH, Hlubocky FJ. Promoting Oncologist Well-Being to Foster Delivery of Ethical, High-Quality Cancer Care: Priorities for 2020 and Beyond. Jco Oncology Practice. 16: 188-190. PMID 32275849 DOI: 10.1200/Op.20.00069  0.387
2020 Hlubocky FJ, Taylor LP, Marron JM, Spence RA, McGinnis MM, Brown RF, McFarland DC, Tetzlaff ED, Gallagher CM, Rosenberg AR, Popp B, Dragnev K, Bosserman LD, Dudzinski DM, Smith S, et al. A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology. Jco Oncology Practice. JOP1900806. PMID 32223701 DOI: 10.1200/Jop.19.00806  0.407
2020 Hlubocky FJ, Peppercorn J, Young K, Cord S, Wroblewski K, Yamada SD, Cella D, Lee NK, Daugherty C. An innovative, internet-based assessment of financial toxicity (FT), psychological distress, and quality of life (QOL) in ovarian cancer survivors (OCS). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E24168  0.422
2019 Cipriano-Steffens TM, Carilli T, Hlubocky F, Quinn M, Fitchett G, Polite B. "Let Go, Let God": A Qualitative Study Exploring Cancer Patients' Spirituality and Its Place in the Medical Setting. Journal of Religion and Health. PMID 31705446 DOI: 10.1007/S10943-019-00942-3  0.438
2019 Garrett SB, Matthews TM, Abramson CM, Koenig CJ, Hlubocky FJ, Daugherty CK, Munster PN, Dohan D. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. Journal of Oncology Practice. JOP1900256. PMID 31603726 DOI: 10.1200/Jop.19.00256  0.476
2019 Peppercorn J, Campbell E, Isakoff S, Horick NK, Rabin J, Quain K, Sequist LV, Bardia A, Collyar D, Hlubocky F, Mathews D. Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear. The Oncologist. PMID 31492767 DOI: 10.1634/Theoncologist.2019-0365  0.339
2019 Mathews DJH, Rabin JT, Quain K, Campbell E, Collyar D, Hlubocky FJ, Isakoff S, Peppercorn J. Secondary Use of Patient Tissue in Cancer Biobanks. The Oncologist. PMID 31182655 DOI: 10.1634/Theoncologist.2018-0376  0.361
2019 Tenner L, Hlubocky FJ, Blanke CD, LeBlanc TW, Marron JM, McGinnis MM, Spence RA, Taylor LP. Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine. Journal of Oncology Practice. 15: 44-49. PMID 30629899 DOI: 10.1200/Jop.18.00432  0.445
2019 Hlubocky FJ, Sher T, Cella D, Ratain MJ, Daugherty C. Till death do us part: Existential loneliness (EL), psychosocial distress, and survival of advanced cancer patients (ACPs), and their spousal caregivers (SCs). Journal of Clinical Oncology. 37: 11628-11628. DOI: 10.1200/Jco.2019.37.15_Suppl.11628  0.715
2019 Daugherty C, Johnson J, Levine SK, Wroblewski K, Lane B, Dale W, Malec M, Hlubocky FJ. Lower costs of care, improved discharge disposition, and improved survival of advanced cancer patients (ACP) receiving early inpatient palliative care (PC) compared to standard oncologic care (SOC). Journal of Clinical Oncology. 37: 11609-11609. DOI: 10.1200/Jco.2019.37.15_Suppl.11609  0.385
2018 Hlubocky FJ, Sachs GA, Larson ER, Nimeiri HS, Cella D, Wroblewski KE, Ratain MJ, Peppercorn JM, Daugherty CK. Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017733592. PMID 29985748 DOI: 10.1200/Jco.2017.73.3592  0.315
2018 Hlubocky FJ, Kass NE, Roter D, Larson S, Wroblewski KE, Sugarman J, Daugherty CK. Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials. Journal of Oncology Practice. JOP1800028. PMID 29787333 DOI: 10.1200/Jop.18.00028  0.486
2018 Polite BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, Cheng Y, Brewer KC, Rauscher GH, Fitchett GA. Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations. Cancer. PMID 29579340 DOI: 10.1002/Cncr.31351  0.387
2018 Lee NK, Anderson D, Hlubocky FJ. Pathway to support and growth: Feasibility of formalized peer mentoring in gynecologic cancer survivorship. Journal of Clinical Oncology. 36: 164-164. DOI: 10.1200/Jco.2018.36.7_Suppl.164  0.425
2018 Daugherty C, Johnson J, Levine SK, Wroblewski K, Lane B, Dale W, Malec M, Hlubocky FJ. Cost of care, discharge disposition, and survival of advanced cancer patients (ACP) receiving early inpatient palliative care (PC) compared to standard oncologic care (SOC) without palliative care. Journal of Clinical Oncology. 36: 130-130. DOI: 10.1200/Jco.2018.36.34_Suppl.130  0.351
2018 Hoppenot C, Chor J, Hlubocky FJ, Yamada SD, Lee NK. Integration of palliative care consultation for patients with malignant bowel obstruction in gynecologic oncology: Qualitative approach to understand provider perspectives. Journal of Clinical Oncology. 36: 116-116. DOI: 10.1200/Jco.2018.36.34_Suppl.116  0.385
2018 Peppercorn JM, Horrick N, Rabin J, Quain KM, Hlubocky FJ, Collyar D, Sequist LV, Bardia A, Isakoff SJ, Campbell E, Mathews D. Patient attitudes towards biobanks and preferences for use of archived biospecimens. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E18612  0.371
2018 Hlubocky FJ, Johnson J, Levine SK, Wroblewski K, Lane B, Dale W, Malec M, Daugherty C. Survival of advanced cancer patients (ACP) receiving early inpatient palliative care (PC) compared to standard oncologic care (SOC) without palliative care. Journal of Clinical Oncology. 36: 10022-10022. DOI: 10.1200/Jco.2018.36.15_Suppl.10022  0.371
2018 Peppercorn J, Campbell E, Rabin J, Quain K, Hlubocky F, Colyar D, Sequist L, Bardia A, Horick N, Isakoff S, Mathews D. Abstract PD8-06: Attitudes towards use of archived biospecimens among patients with cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd8-06  0.433
2018 Amico A, Fang R, Raoul A, Wroblewski K, Nielsen S, Weipert C, Abe H, Sheth D, Romero I, Kulkarni K, Schacht D, Patrick-Miller L, Verp M, Bradbury A, Hlubocky F, et al. Abstract P5-19-04: Psychosocial impact of a multi-modality surveillance program for women at high-risk for breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P5-19-04  0.376
2017 Garrett SB, Koenig CJ, Trupin L, Hlubocky FJ, Daugherty CK, Reinert A, Munster P, Dohan D. What advanced cancer patients with limited treatment options know about clinical research: a qualitative study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 28488050 DOI: 10.1007/S00520-017-3734-4  0.438
2017 Malec M, Hlubocky FJ, Levine SK, Wroblewski K, Thomas A, Lane B, Dale W, Daugherty C. Early specialist palliative care for all hospitalized advanced cancer patients (ACP)? Effect of “up-front” versus “on demand” palliative care on outcomes. Journal of Clinical Oncology. 35: 172-172. DOI: 10.1200/Jco.2017.35.31_Suppl.172  0.375
2017 Hlubocky FJ, Sher T, Cella D, Yap BJ, Ratain MJ, Peppercorn J, Daugherty C. The impact of sleep disturbances (SD) on quality of life, psychological morbidity, and survival of advanced cancer patients (ACP) and caregivers (CG). Journal of Clinical Oncology. 35: 10115-10115. DOI: 10.1200/Jco.2017.35.15_Suppl.10115  0.735
2017 Malec M, Hlubocky FJ, Levine SK, Wroblewski K, Lane B, Thomas A, Dale W, Daugherty C. Early specialist palliative care for all hospitalized, advanced cancer patients (ACP)? Better outcomes with “up-front” versus “on-demand” palliative care. Journal of Clinical Oncology. 35: 10026-10026. DOI: 10.1200/Jco.2017.35.15_Suppl.10026  0.365
2016 de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella D. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity. Cancer. PMID 27716900 DOI: 10.1002/Cncr.30369  0.381
2016 Dunn LB, Wiley J, Garrett S, Hlubocky F, Daugherty C, Trupin L, Munster P, Dohan D. Interest in Initiating an Early Phase Clinical Trial: Results of a Longitudinal Study of Advanced Cancer Patients. Psycho-Oncology. PMID 27233054 DOI: 10.1002/Pon.4179  0.495
2016 Bellavance E, Peppercorn J, Kronsberg S, Greenup R, Keune J, Lynch J, Collyar D, Magder L, Tilburt J, Hlubocky F, Yao K. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy. Annals of Surgical Oncology. PMID 27169770 DOI: 10.1245/S10434-016-5253-9  0.38
2016 Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert S. An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population. Journal of Racial and Ethnic Health Disparities. PMID 26983622 DOI: 10.1007/S40615-016-0211-6  0.426
2016 Muffly LS, Hlubocky FJ, Khan N, Wroblewski K, Breitenbach K, Gomez J, McNeer JL, Stock W, Daugherty CK. Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 122: 954-61. PMID 26749023 DOI: 10.1002/Cncr.29868  0.361
2015 Hlubocky FJ, Ratain MJ, Siegler M, Daugherty C. PI-REAL: A study of informed consent (IC) communication in real-time during phase I clinical trial encounters. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 22. PMID 28148149 DOI: 10.1200/Jco.2015.33.29_Suppl.22  0.404
2015 Pentz RD, Hendershot KA, Wall L, White TE, Peterson SK, Thomas CB, McCormick J, Green MJ, Lewis C, Farmer ZL, Hlubocky FJ, Dossul T, Dixon MD, Liu Y, Switchenko JM, et al. Development and testing of a tool to assess patient preferences for phase I clinical trial participation. Psycho-Oncology. 24: 835-8. PMID 25530552 DOI: 10.1002/Pon.3731  0.328
2015 Polite BN, Cipriano TM, Hlubocky FJ, Jean-Pierre P, Brewer K, Cheng Y, Rauscher GH, Fitchett G. Religious beliefs and stage at diagnosis in a biracial sample of newly diagnosed colon cancer patients. Journal of Clinical Oncology. 33: 6556-6556. DOI: 10.1200/Jco.2015.33.15_Suppl.6556  0.429
2014 Wiley J, Garrett SB, Trupin L, Hlubocky FJ, Daugherty C, Reinert A, Munster PN. Social and emotional factors and decisions of advanced cancer patients (ACP) to enter an early-phase (EP) clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 223. PMID 28142779 DOI: 10.1200/Jco.2014.32.31_Suppl.223  0.379
2014 Yap BJ, Hlubocky FJ, Daugherty C. Relationship between the cancer-specific comprehensive score for financial toxicity (COST), patient-reported outcome, and health-related quality of life (HRQOL) in patients with advanced cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 222. PMID 28142777 DOI: 10.1200/Jco.2014.32.31_Suppl.222  0.464
2014 de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CK. The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer. 120: 3245-53. PMID 24954526 DOI: 10.1002/Cncr.28814  0.382
2014 Dohan DP, Trupin L, Koenig C, Hlubocky FJ, Daugherty C. Understanding of early-phase clinical trials among a cohort of advanced cancer patients with limited standard treatment options. Journal of Clinical Oncology. 32: 9651-9651. DOI: 10.1200/Jco.2014.32.15_Suppl.9651  0.444
2014 Hlubocky FJ, Cella D, Sher T, Ratain MJ, Daugherty C. Marital distress (MD), quality of life, and psychological morbidity among advanced cancer patients (ACP) in phase I trials and their spousal caregivers (SC). Journal of Clinical Oncology. 32: 9578-9578. DOI: 10.1200/Jco.2014.32.15_Suppl.9578  0.716
2013 Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, Grunfeld E, Del Giudice ME, Ward LA, Galliher JM, Oeffinger KC, Henderson TO. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. Journal of Cancer Survivorship : Research and Practice. 7: 275-82. PMID 23471729 DOI: 10.1007/S11764-013-0271-0  0.353
2013 Hlubocky FJ, Webster K, Beaumont J, Cashy J, Paul D, Abernethy A, Syrjala KL, Von Roenn J, Cella D. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index. Leukemia & Lymphoma. 54: 1942-6. PMID 23320888 DOI: 10.3109/10428194.2012.762977  0.432
2013 Wagner LI, Berg SR, Gandhi M, Hlubocky FJ, Webster K, Aneja M, Cella D, Lacouture ME. The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18). Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1033-41. PMID 23128934 DOI: 10.1007/S00520-012-1623-4  0.395
2013 Souza JAD, Yap B, Hlubocky FJ, Ratain MJ, Cella D, Daugherty C. The development of a financial toxicity patient-reported outcome instrument (PRO) in cancer. Journal of Clinical Oncology. 31: 6612-6612. DOI: 10.1200/Jco.2013.31.15_Suppl.6612  0.385
2013 Muffly LS, Hlubocky FJ, Gomez J, Breitenbach K, Lappe M, McNeer J, Stock W, Daugherty CK. Suffering Before The Cure: Evaluation Of Psychological Morbidities In Adolescents and Young Adults With Hematologic Malignancies In Early Survivorship Blood. 122: 771-771. DOI: 10.1182/Blood.V122.21.771.771  0.407
2012 Spill GR, Hlubocky FJ, Daugherty CK. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer. Pm & R : the Journal of Injury, Function, and Rehabilitation. 4: 96-108. PMID 22373458 DOI: 10.1200/Jco.2008.26.15_Suppl.6623  0.442
2012 Pentz RD, Liu Y, Wall L, Daugherty C, Green MJ, Hlubocky FJ, Peterson SK, Sun CC, Dixon M, Harvey RD, Owonikoko TK, Khuri FR. Physicians’ ability to correctly identify values important to cancer patients enrolled in phase I clinical trials. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E13026  0.437
2012 Hlubocky FJ, Cella D, Sher TG, Ratain MJ, Daugherty C. Financial burdens (FB), quality of life, and psychological distress among advanced cancer patients (ACP) in phase I trials and their spousal caregivers (SC). Journal of Clinical Oncology. 30: 6117-6117. DOI: 10.1200/Jco.2012.30.15_Suppl.6117  0.745
2011 Henderson TO, Nathan PC, Kigin M, Hlubocky FJ, Wroblewski K, Stewart TV, Galliher JM, Oeffinger KC, Daugherty C. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: A survey of the American Academy of Family Physicians (AAFP). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9128. PMID 28022419 DOI: 10.1200/Jco.2011.29.15_Suppl.9128  0.368
2011 Daugherty C, Hlubocky FJ, Kass NE, Roter D, Larson S, Sugarman J, Wroblewski K, Ratain MJ. Physician-investigator (PI) and patient communication regarding altruism and non-therapeutic benefits in phase I trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e16579. PMID 28022084 DOI: 10.1200/Jco.2011.29.15_Suppl.E16579  0.409
2011 Pentz RD, Farmer ZL, Green MJ, Daugherty C, Hlubocky FJ, Peterson SK, Sun CC, Lewis CM, Owonikoko TK, Khuri FR, Harvey RD. Assessing patients' values when standard-of-care options are exhausted. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9108. PMID 28021822 DOI: 10.1200/Jco.2011.29.15_Suppl.9108  0.409
2011 Hlubocky FJ, Sher TG, Wroblewski K, Ratain MJ, Daugherty C. Associations between symptom burdens (SB) and expectations of benefit (EB) for advanced cancer patients (ACP) and spousal caregivers (SC) participating in phase I trials. Journal of Clinical Oncology. 29. DOI: 10.1200/Jco.2011.29.15_Suppl.E19595  0.736
2010 Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 878-83. PMID 20038717 DOI: 10.1200/Jco.2009.25.6107  0.349
2010 Kigin M, Hlubocky FJ, Wroblewski K, Daugherty C, Henderson TO. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: A survey of ASCO oncologists. Journal of Clinical Oncology. 28: 9560-9560. DOI: 10.1200/Jco.2010.28.15_Suppl.9560  0.39
2010 Hlubocky FJ, Sher TG, Wroblewski K, Luzar E, Ratain MJ, Daugherty C. Expectations of benefit and symptom burdens among advanced cancer patients (ACP) and spousal caregivers during the course of phase I trials. Journal of Clinical Oncology. 28: 9059-9059. DOI: 10.1200/Jco.2010.28.15_Suppl.9059  0.744
2010 Daugherty C, Hlubocky FJ, Kass NE, Roter D, Larson S, Sugarman J, Wroblewski K, Ratain MJ. Communication of the essential elements of informed consent (IC) for research: A RIAS analysis of phase I clinical trial encounters. Journal of Clinical Oncology. 28: 6045-6045. DOI: 10.1200/Jco.2010.28.15_Suppl.6045  0.415
2010 Polite BN, Smith DM, Ray M, Hlubocky FJ, Olopade OI, Daugherty C, Gehlert SJ. Evaluating psychosocial and belief differences in a diverse racial and socioeconomic cancer population. Journal of Clinical Oncology. 28: 6036-6036. DOI: 10.1200/Jco.2010.28.15_Suppl.6036  0.377
2009 Hlubocky FJ, Larson E, Ratain MJ, Sachs G, Daugherty CK. Cognitive function (CF) and prognostic information understanding in advanced cancer patients (ACP). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9516. PMID 27964487 DOI: 10.1200/Jco.2009.27.15_Suppl.9516  0.382
2009 Daugherty C, Kass NE, Roter D, Larson S, Sugarman J, Kasza K, Ratain MJ, Hlubocky FJ. A study of physician investigator (PI) disclosure of alternatives of care and prognostic information to advanced cancer patients (ACP) enrolling in phase I trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6508. PMID 27964011 DOI: 10.1200/Jco.2009.27.15_Suppl.6508  0.437
2009 Henderson TO, Hlubocky F, Diller L, Daugherty C. Preferences and knowledge gaps among pediatric oncologists regarding the care of childhood cancer survivors: A survey of nearly 1,200 physicians. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6561. PMID 27963799 DOI: 10.1200/Jco.2009.27.15_Suppl.6561  0.384
2009 Kass NE, Sugarman J, Medley AM, Fogarty LA, Taylor HA, Daugherty CK, Emerson MR, Goodman SN, Hlubocky FJ, Hurwitz HI, Carducci M, Goodwin-Landher A. An intervention to improve cancer patients' understanding of early-phase clinical trials. Irb. 31: 1-10. PMID 19552233  0.366
2009 Bradbury A, Patrick-Miller L, Li T, Egleston B, Sands C, Schmidheiser H, Hlubocky F, Olopade O, Daly M, Daugherty C. Should Minors Be Offered BRCA1/2 Testing for Hereditary Breast Cancer? Opinions of Parents Who Have Undergone BRCA1/2 Testing. Cancer Research. 69: 4071-4071. DOI: 10.1158/0008-5472.Sabcs-09-4071  0.322
2008 Daugherty CK, Hlubocky FJ. What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5988-93. PMID 19029419 DOI: 10.1200/Jco.2008.17.2221  0.455
2008 Lee RT, Hlubocky FJ, Hu JJ, Stafford RS, Daugherty CK. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM). Integrative Cancer Therapies. 7: 70-5. PMID 18505899 DOI: 10.1177/1534735408319059  0.399
2008 Harding GA, Hlubocky FJ, Siegler M, Daugherty CK. Canadian oncologist communication about prognosis disclosure with their terminally-ill patients Journal of Clinical Oncology. 26: 6554-6554. DOI: 10.1200/Jco.2008.26.15_Suppl.6554  0.385
2008 Hlubocky FJ, Larson E, Sachs G, Lesniak MS, Ratain MJ, Daugherty CK. A study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials Journal of Clinical Oncology. 26: 9523-9523. DOI: 10.1200/Jco.2007.25.18_Suppl.6548  0.378
2008 Spill GR, Daugherty C, Hlubocky FJ, Siegler M. Poster 23: Oncologists' and Physiatrists' Attitudes Regarding Rehabilitation for Patients With Advanced Cancer Archives of Physical Medicine and Rehabilitation. 89. DOI: 10.1016/J.Apmr.2008.09.049  0.472
2007 Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CK. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3488-94. PMID 17687154 DOI: 10.1200/Jco.2007.11.7283  0.502
2007 Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 548-54. PMID 17290064 DOI: 10.1200/Jco.2005.03.9800  0.47
2007 Smith D, Polite BN, Hlubocky F, Gehlert S, Daugherty CK. Beliefs and concerns African American (AA) and white (W) patients (pts) with breast, lung, and colon cancer bring to bear on the decision to undergo chemotherapy Journal of Clinical Oncology. 25: 9076-9076. DOI: 10.1200/Jco.2007.25.18_Suppl.9076  0.417
2007 Bruce JY, Hlubocky FJ, Daugherty CK. “Was it worth it?” A pilot study of advanced cancer patients’ retrospective perceptions of benefit from phase I trial participation Journal of Clinical Oncology. 25: 19670-19670. DOI: 10.1200/Jco.2007.25.18_Suppl.19670  0.476
2007 Lee RT, Hlubocky FJ, Hu JJ, Stafford R, Daugherty CK. A pilot international survey of oncologists’ opinions and self-reported practice patterns on complementary and alternative medicine Journal of Clinical Oncology. 25: 19526-19526. DOI: 10.1200/Jco.2007.25.18_Suppl.19526  0.371
2007 Bruce JY, Hlubocky FJ, Daugherty CK. 4 “Was It Worth It?” A Pilot Study Of Advanced Cancer Patients' Retrospective Perceptions Of Benefit From Phase I Trial Participation. Journal of Investigative Medicine. 55. DOI: 10.1136/Jim-55-02-04  0.481
2006 Daugherty CK, Hlubocky FJ, Gray S, Ratain MJ. Patients involved in clinical research are more concerned about intrinsic and traditional research ("publish or perish") conflicts of interests (COI) than potential financial conflicts: Results of interviews with advanced cancer patients enrolling in phase I trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 6008. PMID 27954646 DOI: 10.1200/Jco.2006.24.18_Suppl.6008  0.43
2006 Wallace JA, Hlubocky FJ, Daugherty CK. Emotional responses of oncologists when disclosing prognostic information to patients with terminal disease: Results of qualitative data from a mailed survey to ASCO members Journal of Clinical Oncology. 24: 8520-8520. DOI: 10.1200/Jco.2006.24.18_Suppl.8520  0.352
2006 Hlubocky FJ, Daugherty CK. Examining the dilemmas of prognostic information disclosure and understanding in those with terminal cancer: In-depth interviews with advanced cancer patients in phase I trials Journal of Clinical Oncology. 24: 8516-8516. DOI: 10.1200/Jco.2006.24.18_Suppl.8516  0.522
2006 Polite BN, Gehlert S, Hlubocky F, Smith D, Daugherty CK. Using qualitative data to examine disparities in cancer outcomes: Results from interviews with African American (AA) and white (W) patients regarding health beliefs and perceptions of chemotherapy Journal of Clinical Oncology. 24: 16016-16016. DOI: 10.1200/Jco.2006.24.18_Suppl.16016  0.419
2005 Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro J. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology. 14: 135-46. PMID 15386780 DOI: 10.1002/Pon.829  0.532
2005 Teitelbaum UR, Hlubocky FJ, Daugherty CK. Survival and informed consent understanding of elderly advanced cancer patients enrolling in phase I trials Journal of Clinical Oncology. 23: 8109-8109. DOI: 10.1200/Jco.2005.23.16_Suppl.8109  0.465
2005 Daugherty CK, Hlubocky FJ. How do cancer physicians say they discuss prognosis with their terminally-ill patients? A survey of ASCO members Journal of Clinical Oncology. 23: 8005-8005. DOI: 10.1200/JCO.2005.23.16_SUPPL.8005  0.355
2005 Hlubocky FJ, Helft PR, Daugherty CK. Hope, decision making, and use of the internet and other media among cancer clinical trials participants Journal of Clinical Oncology. 23: 6068-6068. DOI: 10.1200/Jco.2005.23.16_Suppl.6068  0.466
2004 Undevia SD, Hlubocky FJ, Goh BC, Ratain MJ, Daugherty CK. Patients (pts) understanding of phase II trial designs and informed consent (IC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 6011. PMID 28015125 DOI: 10.1200/Jco.2004.22.14_Suppl.6011  0.341
2004 Gray SW, Hlubocky F, Daugherty CK. Education and gender differences in perception of prognosis among advanced cancer patients (ACP) in hospice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 6022. PMID 28015103 DOI: 10.1200/Jco.2004.22.14_Suppl.6022  0.414
2004 Daugherty CK, Stein N, Trabasso T, Hlubocky FJ. A new “gold standard” for assessment of prognosis (prog) understanding among advanced cancer patients (acp): Narrative interviews of patients in phase I trials and invested third party observers (itpo) Journal of Clinical Oncology. 22: 8134-8134. DOI: 10.1200/JCO.2004.22.90140.8134  0.423
2004 Hlubocky FJ, Kass NE, Fogarty LA, Sugarman J, Daugherty CK. Effects of a CD-ROM educational intervention (CD) on prognosis (prog) understanding among advanced cancer patients (acp) enrolling in early phase clinical trials Journal of Clinical Oncology. 22: 6054-6054. DOI: 10.1200/Jco.2004.22.90140.6054  0.385
2003 Helft PR, Hlubocky F, Wen M, Daugherty CK. Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials. Supportive Care in Cancer. 11: 644-651. PMID 12883963 DOI: 10.1007/S00520-003-0496-Y  0.534
2003 Helft PR, Hlubocky F, Daugherty CK. American Oncologists’ Views of Internet Use by Cancer Patients: A Mail Survey of American Society of Clinical Oncology Members Journal of Clinical Oncology. 21: 942-947. PMID 12610198 DOI: 10.1200/Jco.2003.08.007  0.39
2003 Hlubocky F, Kass N, Fogarty L, Sugarman J, Daugherty C. 545 A randomized trial of a cd-rom educational intervention for advanced cancer patients (acp) enrolling in early phase trials European Journal of Cancer Supplements. 1: S165. DOI: 10.1016/S1359-6349(03)90577-5  0.305
Show low-probability matches.